Nedbank Group Earnings Call Transcripts
Fiscal Year 2025
-
Headline earnings grew 2% and ROE reached 15.4%, supported by strong deposit growth, digital adoption, and strategic acquisitions. Guidance for 2026 targets mid-single digit NII growth, a CET1 ratio within 11%-12.5%, and ROE above 15%.
-
Strong fee and commission growth in PPB and market share gains in secured lending offset slower CIB deal flow, with advances growth expected to accelerate in 2026. Capital and liquidity remain robust, and strategic initiatives like the iKhokha acquisition target SME and mass market expansion.
-
Diluted HEPS rose 7% and ROE improved to 15.2% in H1 2025, with strong capital and digital growth. ETI investment is now held for sale, and guidance for 2025 is more cautious amid macro headwinds, with a focus on cost control, digital, and capital optimization.
Fiscal Year 2024
-
Diluted HEPS rose 11% and ROE reached 15.8% in 2024, driven by strong NIR growth, lower impairments, and cost control. Strategic initiatives and a major organizational restructure aim to boost long-term ROE above 18% amid a challenging macroeconomic environment.
-
Strong H1 2024 results with headline EPS up 12%, ROE at 15%, and an 11.5% dividend increase, driven by lower impairments and NIR growth. Outlook is cautiously optimistic, with improved macro conditions and a focus on further cost and capital efficiencies.